Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
Wuquan Deng,1,* Sheng Qiu,1,* Gangyi Yang,2 Bing Chen1 1Department of Endocrinology, Southwest Hospital, Third Military Medical University, 2Department of Endocrinology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of China *These authors contribut...
Saved in:
Main Authors: | Deng W (Author), Qiu S (Author), Yang G (Author), Chen B (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
by: Inaishi J, et al.
Published: (2022) -
Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China
by: Shanshan Hu, et al.
Published: (2022) -
Exenatide Use in the Management of Type 2 Diabetes Mellitus
by: Angelos Kyriacou, et al.
Published: (2010) -
Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes
by: Zhang Y, et al.
Published: (2021) -
A review of exenatide as adjunctive therapy in patients with type 2 diabetes
by: Gisela I Robles, et al.
Published: (2009)